Literature DB >> 24051001

New insights in the role of nucleoporins: a bridge leading to concerted steps from HIV-1 nuclear entry until integration.

Francesca Di Nunzio1.   

Abstract

Human Immunodeficiency virus type 1 (HIV-1), as well as many other viruses that depend on nuclear entry for replication, has developed an evolutionary strategy to dock and translocate through the nuclear pore complex (NPC). In particular, the nuclear pore is not a static window but it is a dynamic structure involved in many vital cellular functions, as nuclear import/export, gene regulation, chromatin organization and genome stability. This review aims to shed light on viral mechanisms developed by HIV-1 to usurp cellular machinery to favor viral gene expression and their replication. In particular, it will be reviewed both what is known and what is speculated about the link between HIV translocation through the nuclear pore and the proviral integration in the host chromatin.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Capsid (CA); Cyclophilin A (CypA); Cyclosporin A (CsA); Nuclear pore complex (NPC); Nucleoporins (Nups); Pre-integration complex (PIC)

Mesh:

Substances:

Year:  2013        PMID: 24051001     DOI: 10.1016/j.virusres.2013.09.003

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

Review 1.  The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways.

Authors:  Ailie Marx; Akram Alian
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

2.  CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.

Authors:  Douglas K Fischer; Akatsuki Saito; Christopher Kline; Romy Cohen; Simon C Watkins; Masahiro Yamashita; Zandrea Ambrose
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

Review 3.  Impact of Nucleoporin-Mediated Chromatin Localization and Nuclear Architecture on HIV Integration Site Selection.

Authors:  Richard W Wong; João I Mamede; Thomas J Hope
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

4.  SUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV.

Authors:  Daniel A Donahue; Sonia Amraoui; Francesca di Nunzio; Camille Kieffer; Françoise Porrot; Silvana Opp; Felipe Diaz-Griffero; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 5.  Cellular and molecular mechanisms of HIV-1 integration targeting.

Authors:  Alan N Engelman; Parmit K Singh
Journal:  Cell Mol Life Sci       Date:  2018-02-07       Impact factor: 9.261

6.  Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.

Authors:  Akatsuki Saito; Damien Ferhadian; Gregory A Sowd; Erik Serrao; Jiong Shi; Upul D Halambage; Samantha Teng; Juan Soto; Mohammad Adnan Siddiqui; Alan N Engelman; Christopher Aiken; Masahiro Yamashita
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

7.  Chromatin organization at the nuclear pore favours HIV replication.

Authors:  Mickaël Lelek; Nicoletta Casartelli; Danilo Pellin; Ermanno Rizzi; Philippe Souque; Marco Severgnini; Clelia Di Serio; Thomas Fricke; Felipe Diaz-Griffero; Christophe Zimmer; Pierre Charneau; Francesca Di Nunzio
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

8.  DNA Physical Properties and Nucleosome Positions Are Major Determinants of HIV-1 Integrase Selectivity.

Authors:  Monica Naughtin; Zofia Haftek-Terreau; Johan Xavier; Sam Meyer; Maud Silvain; Yan Jaszczyszyn; Nicolas Levy; Vincent Miele; Mohamed Salah Benleulmi; Marc Ruff; Vincent Parissi; Cédric Vaillant; Marc Lavigne
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 9.  Nuclear entry of DNA viruses.

Authors:  Nikta Fay; Nelly Panté
Journal:  Front Microbiol       Date:  2015-05-13       Impact factor: 5.640

Review 10.  The Viral Capsid: A Master Key to Access the Host Nucleus.

Authors:  Guillermo Blanco-Rodriguez; Francesca Di Nunzio
Journal:  Viruses       Date:  2021-06-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.